| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Karen Marie Johnson is Director at TOIIW and has filed Form 4s across 2 companies. Karen Marie Johnson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Karen Marie Johnson has 8 Form 4 filings on record from March 2022 to July 2026, across 2 companies: Director at The Oncology Institute (TOIIW), 2026; Director at Oncology Institute (TOI), 2022–2025.
The 11 reported transactions were 9 stock awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $38K and no sales.
The only open-market purchase was 36,224 shares of TOI at an average $1.04 on March 26, 2025, about $38K. Twelve months later TOI was up 156%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Director | Buy | 36,224 | $1.04 | $37,734.54 | +21.7% | +94.2% | +156.2% |